Transdermal Clonidine in the Treatment of Severe Hyperemesis Gravidarum

PHASE3CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
Hyperemesis Gravidarum
Interventions
DRUG

Clonidine

transdermal clonidine patch 5 mg q. 5 days

Trial Locations (1)

10126

Ospedale Sant'Anna. Dipartimento di Ostetricia e Neonatologia. Servizio di Medicina Interna, Torino

All Listed Sponsors
lead

A.O.U. Città della Salute e della Scienza

OTHER

NCT01559012 - Transdermal Clonidine in the Treatment of Severe Hyperemesis Gravidarum | Biotech Hunter | Biotech Hunter